TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

Clinical trial NCT01851369 · COMPLETED

Trial details

NCT number: NCT01851369
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphomas Solid Tumors NSCLC Metastatic Colon Carcinoma Granulosa Cell Ovarian Cancer

Start date: 2013-07-12
Primary completion: 2023-08-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.